MedTrace Logo

The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study)

NCT01466426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2014-10-28

No results posted yet for this study

Summary

This pilot study aims at validating 18F-flourodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in the detection and characterization of venous thromboembolism (VTE) in the entire human body, especially deep venous thrombosis (DVT) and pulmonary embolism (PE). On completion of this study the investigators will hopefully be able to demonstrate the importance of functional/molecular imaging technique in managing patients with this common and potentially fatal disorder.

Conditions

  • Venous Thromboembolic Disease

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Soeren Hess, MD · Odense University Hospital

  • Poul Henning Madsen, MD · Odense University Hospital

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-12-31
Completion
2014-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01466426 on ClinicalTrials.gov